SPDR S&P Pharmaceuticals ETF
XPH
XPH
70 hedge funds and large institutions have $154M invested in SPDR S&P Pharmaceuticals ETF in 2018 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 13 increasing their positions, 28 reducing their positions, and 12 closing their positions.
Holders
70
Holders Change
-5
Holders Change %
-6.67%
% of All Funds
1.6%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
7
Increased
13
Reduced
28
Closed
12
Calls
–
Puts
$529K
Net Calls
-$529K
Net Calls Change
-$295K
Top Buyers
Top Sellers
| 1 |
BB
1
Bell Bank
Fargo,
North Dakota
|
$0 |
| 2 |
2
Morgan Stanley
New York
|
$25.1M |
| 3 |
AL
3
Arnhold LLC
New York
|
$0 |
| 4 |
4
Jane Street
New York
|
$225K |
| 5 |
5
Bank of America
Charlotte,
North Carolina
|
$13.3M |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
RJFSA
76
Raymond James Financial Services Advisors
St. Petersburg,
Florida
| – | – | -5,665 | Closed |
|
|
SWP
77
Stratos Wealth Partners
Beachwood,
Ohio
| – | – | -2,365 | Closed |
|
78
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| – | – | -564 | Closed |
|
|
SFSIG
79
San Francisco Sentry Investment Group
San Francisco,
California
| – | – | -114 | Closed |
|
|
CG
80
Cutler Group
San Francisco,
California
| – | – | -100 | Closed |
|
|
SBL
81
Sargent Bickham Lagudis
Boulder,
Colorado
| – | – | -17 | Closed |
|
82
Parallax Volatility Advisers
San Francisco,
California
| $0 | 2 | – | – |
|